10 results
10-K
2019 FY
AKRO
Akero Therapeutics Inc
16 Mar 20
Annual report
5:17pm
in the European Union Member States. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative
424B4
AKRO
Akero Therapeutics Inc
20 Jun 19
Prospectus supplement with pricing info
5:20pm
, or professional codes of conduct, applicable in the European Union Member States. Failure to comply with these requirements could result in reputational risk, public
S-1/A
ni8kdecwy 2z
10 Jun 19
IPO registration (amended)
11:16am
S-1
o73d3dm oy9u1svmq6
24 May 19
IPO registration
4:18pm
DRS/A
7tnak76jqcr3djp
30 Apr 19
Draft registration statement (amended)
12:00am
DRS/A
382d67 8l5d
19 Mar 19
Draft registration statement (amended)
12:00am
DRS
m99u4e dgnlfllya
17 Jan 19
Draft registration statement
12:00am
- Prev
- 1
- Next